Manufacture of a Stable Lyophilized Formulation of the Live Attenuated Pertussis Vaccine BPZE1
Current pertussis vaccines protect against disease, but not against colonization by and transmission of <i>Bordetella pertussis</i>, whereas natural infection protects against both. The live attenuated vaccine BPZE1 was developed to mimic immunogenicity of natural infection without causi...
Main Authors: | Marcel Thalen, Anne-Sophie Debrie, Loic Coutte, Dominique Raze, Ken Solovay, Keith Rubin, Nathalie Mielcarek, Camille Locht |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/8/3/523 |
Similar Items
-
Pertussis vaccines and the role of <I>Bordetella pertussis</I> lipooligosaccharide in the immune response to pertussis infection and vaccination
by: I. A. Alekseeva, et al.
Published: (2021-03-01) -
Acellular and "low" pertussis vaccines: adverse events and the role of mutations Vacinas pertussis acelular e pertussis "low": eventos adversos e o papel das mutações
by: Hisako G. Higashi, et al.
Published: (2009-06-01) -
New features of pertussis vaccination
by: A. P. Cherdantsev, et al.
Published: (2020-06-01) -
Immune persistence after pertussis vaccination
by: Zhiyun Chen, et al.
Published: (2017-04-01) -
Prevention of pertussis: An unresolved problem
by: Susanna Esposito, et al.
Published: (2018-10-01)